|
1
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:332–339. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tomizawa M, Kondo F and Kondo Y: Growth
patterns and interstitial invasion of small hepatocellular
carcinoma. Pathol Int. 45:352–358. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lencioni R, Petruzzi P and Crocetti L:
Chemoembolization of hepatocellular carcinoma. Semin Intervent
Radiol. 30:3–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim HY and Park JW: Clinical trials of
combined molecular targeted therapy and locoregional therapy in
hepatocellular carcinoma: Past, present and future. Liver Cancer.
3:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raoul JL, Gilabert M and Piana G: How to
define transarterial chemoembolization failure or refractoriness: A
European perspective. Liver Cancer. 3:119–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leffert HL and Paul D: Studies on primary
cultures of differentiated fetal liver cells. J Cell Biol.
52:559–568. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumoto K, Yamada K, Kohmura E,
Kinoshita A and Hayakawa T: Role of pyruvate in ischaemia-like
conditions on cultured neurons. Neurol Res. 16:460–464. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohira RH, Dipple KM, Zhang YH and McCabe
ER: Human and murine glycerol kinase: Influence of exon 18
alternative splicing on function. Biochem Biophys Res Commun.
331:239–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ai Y, Jenkins NA, Copeland NG, Gilbert DH,
Bergsma DJ and Stambolian D: Mouse galactokinase: Isolation,
characterization and location on chromosome 11. Genome Res.
5:53–59. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips JW, Jones ME and Berry MN:
Implications of the simultaneous occurrence of hepatic glycolysis
from glucose and gluconeogenesis from glycerol. Eur J Biochem.
269:792–797. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sumida KD, Crandall SC, Chadha PL and
Qureshi T: Hepatic gluconeogenic capacity from various precursors
in young versus old rats. Metabolism. 51:876–880. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wheatley DN, Scott L, Lamb J and Smith S:
Single amino acid (arginine) restriction: Growth and death of
cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem.
10:37–55. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Walker V: Ammonia toxicity and its
prevention in inherited defects of the urea cycle. Diabetes Obes
Metab. 11:823–835. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomizawa M, Toyama Y, Ito C, Toshimori K,
Iwase K, Takiguchi M, Saisho H and Yokosuka O: Hepatoblast-like
cells enriched from mouse embryonic stem cells in medium without
glucose, pyruvate, arginine and tyrosine. Cell Tissue Res.
333:17–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Survival of primary human
hepatocytes and death of induced pluripotent stem cells in media
lacking glucose and arginine. PLoS One. 8:e718972013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamura T, Teramoto H, Tomita Y and
Ichihara A: L-proline is an essential amino acid for hepatocyte
growth in culture. Biochem Biophys Res Commun. 122:884–891. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davies B and Fried M: The L19 ribosomal
protein gene (RPL19): Gene organization, chromosomal mapping, and
novel promoter region. Genomics. 25:372–380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tam S, Clavijo A, Engelhard EK and
Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays
for the detection and serotype determination of foot-and-mouth
disease virus. J Virol Methods. 161:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Simons AL, Mattson DM, Dornfeld K and
Spitz DR: Glucose deprivation-induced metabolic oxidative stress
and cancer therapy. J Cancer Res Ther. 5:(Suppl 1). S2–S6. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Módis K, Gerő D, Stangl R, Rosero O,
Szijártó A, Lotz G, Mohácsik P, Szoleczky P, Coletta C and Szabó C:
Adenosine and inosine exert cytoprotective effects in an in vitro
model of liver ischemia-reperfusion injury. Int J Mol Med.
31:437–446. 2013.PubMed/NCBI
|
|
21
|
Cai H, Jiang D, Qi F, Xu J, Yu L and Xiao
Q: HRP-3 protects the hepatoma cells from glucose
deprivation-induced apoptosis. Int J Clin Exp Pathol.
8:14383–14391. 2015.PubMed/NCBI
|
|
22
|
Feun L, You M, Wu CJ, Kuo MT, Wangpaichitr
M, Spector S and Savaraj N: Arginine deprivation as a targeted
therapy for cancer. Curr Pharm Des. 14:1049–1057. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ju W, Li S, Wang Z, Liu Y and Wang D:
Decorin protects human hepatocma HepG2 cells against oxygen-glucose
deprivation via modulating autophagy. Int J Clin Exp Med.
8:13347–13452. 2015.PubMed/NCBI
|
